Baz2a - bromodomain adjacent to zinc finger domain, 2A Gene
Species: Rattus norvegicus
Summary
Predicted to enable DNA binding activity; RNA binding activity; and lysine-acetylated histone binding activity. Predicted to contribute to RNA polymerase I core promoter sequence-specific DNA binding activity. Predicted to be involved in DNA methylation; histone deacetylation; and negative regulation of transcription by RNA polymerase I. Predicted to act upstream of or within chromatin organization and histone modification. Predicted to be located in cytosol; nuclear lumen; and rDNA heterochromatin. Predicted to be part of chromatin silencing complex. Orthologous to human BAZ2A (bromodomain adjacent to zinc finger domain 2A). [provided by Alliance of Genome Resources, Apr 2022]
Baz2a Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001107158.2 | NP_001100628.2 | bromodomain adjacent to zinc finger domain protein 2A |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
bromodomain adjacent to zinc finger domain protein 2A |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15658 | GSK2801 | 99.86% | Unkown | |
| HY-19336 | BAZ2-ICR | Inhibitor | 99.80% | Unkown |
| HY-77826 | 4-Chloro-N-methylpicolinamide | Inhibitor | 99.89% | Unkown |
| HY-107477 | GSK8573 | 99.53% | Unkown | |
| HY-168448 | dBAZ2 | Degrader | / | Unkown |
| HY-168449 | BAZ2A/B ligand 1 | / | Unkown | |
| HY-168453 | dBAZ2B | Degrader | / | Unkown |
| HY-RS01379 | BAZ2A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18165 | Baz2a Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24639 | Baz2a Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service